We have shown that G-CSF is highly expressed in GI cancers [17,33] and is associated with tumor progression and poor prognosis in several other cancer types, such as prostate [34], neuroblastoma [35], bladder [36], non-small cell lung cancer [37], and head and neck squamous cell carcinomas [38]. This evidence concerns the gene CSF3 and neoplasm.